Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Post by InvrsContrarianon Nov 08, 2021 3:10pm
167 Views
Post# 34101483

Substantial short volume

Substantial short volume Jalapeno and bungalow just play off each other. Almost 20% of vpt volume are the short plays since September. Quite the uptick from summer. But like Mortimer said learn how to trade to take advantage of the shorters tactics. Don't buy hi and sell low unless you see another good play. Just buy low and don't trade if you can't handle the swings. GEHC has a plan and they are preparing a case for vpt. It is one of their many tools they are using to update their diagnostics tool kit. There are articles out their about how GEHC hasn't updated their program in over a decade. Go technology go! Any good researcher will have many projects on the go at any one time. This 4d heart twisting model will bring vpt many new uses and fits in their mission statement. Don't tell me they just developed it in the last few months. It's probably all wrapped up and waiting to be incorporated into the vms3. Nothing is left to luck within the research world. Everything has a plan and a timeline. Good luck to all longs!
<< Previous
Bullboard Posts
Next >>